SMAD4 and adenoma: SB-505124, a TGF-βR1 small molecule inhibitor also had no significant inhibitory effect on Smad4+/+ and Smad4Δ/Δ adenoma growth (1 μM) without the exogenous addition of TGF-β1 (Supplementary Fig. 3).